Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gunz

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Molecular Endocrinology (Baltimore, Md.)|February 27, 2001
Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlatesS Vallette-Kasic, I Pellegrini-Bouiller, F Sampieri, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomasA Barlier, G Gunz, A J Zamora, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomasP Jaquet, L Ouafik, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiencyI Pellegrini-Bouiller, P Bélicar, A Barlier, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Resistance to bromocriptine in prolactinomasI Pellegrini, R Rasolonjanahary, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Expression of the members of the Ptx family of transcription factors in human pituitary adenomasI Pellegrini-Bouiller, C Manrique, G Gunz, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expressionI Pellegrini-Bouiller, I Morange-Ramos, A Barlier, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Molecular Endocrinology (Baltimore, Md.)|February 27, 2001
Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlatesS Vallette-Kasic, I Pellegrini-Bouiller, F Sampieri, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomasA Barlier, G Gunz, A J Zamora, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomasP Jaquet, L Ouafik, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiencyI Pellegrini-Bouiller, P Bélicar, A Barlier, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Resistance to bromocriptine in prolactinomasI Pellegrini, R Rasolonjanahary, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Expression of the members of the Ptx family of transcription factors in human pituitary adenomasI Pellegrini-Bouiller, C Manrique, G Gunz, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expressionI Pellegrini-Bouiller, I Morange-Ramos, A Barlier, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Pageof 4